Brief: McKesson Q2 Adjusted EPS USD 7.07 Vs. IBES Estimate USD 6.88
Nov 06 (Reuters) - McKesson Q2 adjusted net income USD 915 million vs. IBES estimate USD 891.8 million. * Q2 operating income USD 578 million * Q2 revenue USD 93,651 million vs. IBES estimate USD 89,330 million * Q2 EPS USD 1.87 * outlook FY adjusted EPS USD 32.4-33
Recent news on McKesson
See all newsMedia: McKesson's medical unit prices $2.25 billion leveraged loan ahead of IPO- Bloomberg News
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
McKesson expects 2027 profit slightly above estimates on drug distribution strength
McKesson beats Q4 profit estimates, maintains long-term profit growth forecast
Brief: McKesson Q4 Adjusted EPS USD 11.69 Vs. IBES Estimate USD 11.6